Research progress in cancer stem cells and their drug resistance

Chinese Journal of Cancer

Volumn 29, Issue 3, 2010, Pages 261-264

  Yu, Hong ^a   Zhang, Chang Ming ^a   Wu, Yong Shou ^a  

^a The Second People's Hospital of Yunnan Province   (China)

Author keywords

Cancer stem cells; Drug resistance; Stem cells

Indexed keywords

ABC TRANSPORTER; ANTHRACYCLINE DERIVATIVE; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; CANCER RELAPSE; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; DNA REPAIR; DRUG SENSITIVITY; HUMAN; METASTASIS POTENTIAL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH;

EID: 79955832666     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10487     Document Type: Review

References (29)

1. Bach SP, Renehan AG, Potten CS, et al. Stem cells: the intestinal stem cell as a paradigm [J]. Carcinogenesis, 2000,21(3):469-476.
2. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts [J]. Annu Rev Med, 2007,58(1):267-284.
3. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [J]. Nat Rev Cancer, 2005,5(4):275-284.
4. Lou H, Dean M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters [J]. Oncogene, 2007,26(9):1357-1360.
5. Bonnet D, Dick LE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nature Med, 1997,3(7):730-737.
6. Jordan CT. Cancer stem cell biology: from leukemia to solid tumors [J]. Curr Opin Cell Biol, 2004,16(6):708-712.
7. Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumors [J]. Lancet Oncol, 2002,3(8):508-513.
8. Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000,100(1): 57-70.
9. Bonnet D. Cancer stem cells: AMLs show the way [J]. Biochem Soc Trans, 2005,33(6):1531-1533.
10. Shackleton M, Quintana E, Fearon ER, et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution [J]. Cell, 2009,138(5):822-829.
11. Tsai RY. A molecular view of stem cell and cancer cell self-renewal [J]. Int J Biochem Cell Biol, 2004,36(4):684-694.
12. Taipale J, Beaehy PA. The Hedgehog and Wnt signalling pathways in cancer [J]. Nature, 2001,411(6835):349-354.
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA, 2003,100(7):3983-3988.
14. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors [J]. Cancer Res, 2003,63(18):5821-5828.
15. Wang L, Qin HY, Han Y. CSCs research status. [J]. J Cell Mol Immunol, 2005, 21(1):107-109. [in Chinese]
16. - blast compartments in apoptosis resistance in acute myeloid leukemia [J]. Haematologica, 2003,88(5):497-508.
17. Takara K, Sakaeda T, Okumura K. An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy [J]. Curr Pharm Des, 2006,12(3):273-286.
18. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters [J]. Nat Rev Cancer, 2002,2(1):48-58.
19. Morrow CS, Peklak-Scott C, Bishwokarma B, et al. Multidrug resistance protein 1 (MRPl, ABCC1) mediates resistance to mitoxantrone via glulathione-dependent drug efflux [J]. Mol Pharmacol, 2006,69(4):1499-1505.
20. Van Zanden JJ, Geraets L, Wortelboer HM, et al. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells [J]. Biochem Pharmaeol, 2004,67(8):1607-1617.
21. Schinkel AH, Junker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) fomily: all overview [J]. Adv Drug Deliv Rev, 2003,55(1):3-29.
22. Kuo PL, Hsu YL, Kuo YC, et al. The anti-proliferative inhibition of ellipticine in human breast mda-mb-23l cancer cells is through cell cycle arrest and apoptosis induction [J]. Anticancer Drags, 2005,16(7):789-795.
23. Eisele L, Klein-Hitpass L, Chatzimanolis N, et al. Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia [J]. Aeta Haematol, 2007,117(1):8-15.
24. Domen J, Weissman IL. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other [J]. J Exp Med, 2000,192(12):1707-1718.
25. Bao S, Wu Q, Sathornsumetee S, et al. Glioma stem cells promote radioresistance by proferential activation of the DNA damage response [J]. Nature, 2006,444(7120):756-760.
26. Li L, Neaves WB. Normal stem cells and cancer stem cells:the niche matters [J]. Cancer Res, 2006,66(9):4553-4557.
27. Yatabe N, Kyo S, Maida Y, et al. HIF-1-mediated activation of telomerase in cervical cancer cells [J]. Oncogene, 2004,23(20):3708-3715.
28. Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindautumour suppressor pVHL [J]. Nature, 2003,425(6955):307-311.
29. Koshiji M, To KK, Hammer S, et al. HIF-1alpha induces genetic instability by transcriptionally down regulating Mut-Salpbu expression [J]. Mol Cell, 2005,17(6):793-803.